Piața farmaceutică din România: rezultate 2013 și perspective 2014

Report
Piața farmaceutică din România:
rezultate 2013 și perspective 2014
20 februarie 2014
Agenda
 Rezultate 2013
 Perspective 2014
 Intrebări şi răspunsuri
2
This document should not be distributed without Cegedim authorization – Copyright 2011
01
Rezultate 2013
3
This document should not be distributed without Cegedim authorization – Copyright 2011
Rezultate trim.4
VOLUM
Canal/
Segment
ZILE DE
TRATAMENT
VALOARE PPP
Variație
(+/- %)
Cota
Piaţă
(%)
Variație
(+/- %)
Cota
Piaţă
(%)
100,0
-3,6
100,0
-1,1
100,0
3.055,8
-2,4
686,4
-0,8
Retail
95,1
-3,6
97,8
-0,9
86,2
2.634,1
-2,8
591,7
-1,2
- Rx
65,8
-4,4
85,9
-0,9
81,2
2.139,1
-4,2
480,5
-2,7
- OTC
34,2
-2,1
14,1
-0,7
18,8
495,0
4,0
111,2
5,7
Spital
4,9
-3,1
2,2
-9,3
13,8
421,7
0,3
94,7
1,9
Cota
Piaţă
(%)
Total piaţă
RON
mil. RON (+/- %)
EUR
mil. EUR (+/- %)
4
This document should not be distributed without Cegedim authorization – Copyright 2011
Rezultate 2013
VOLUM
Canal/
Segment
Cota
Piaţă
(%)
Total piaţă
ZILE DE
TRATAMENT
Variație
(+/- %)
Cota
Piaţă
(%)
100,0
-1,1
Retail
95,1
- Rx
VALOARE PPP
Variație
(+/- %)
Cota
Piaţă
(%)
RON
mil. RON (+/- %)
100,0
0,2
100,0
11.748,9
0,3
2.658,9
1,1
-1.0
97,8
0,4
86,6
10.168,8
0,4
2.301,3
1,3
67,6
-1,3
86,5
0,6
82,5
8.388,9
-0,8
1.898,5
0,1
- OTC
32,4
-0,2
13,5
-0,6
17,5
1.779,8
6,5
402,8
7,4
Spital
4,9
-3,1
2,2
-6,4
13,4
1.580,2
-0,5
357,6
0,4
EUR
mil. EUR (+/- %)
5
This document should not be distributed without Cegedim authorization – Copyright 2011
Principalele grupe terapeutice (ATC1)
PREŢ
MEDIU
VOLUM
VALOARE PPP
Cota de
piaţă
(%)
Variaţie
(+/- %)
11.748,9
100.0
0,3
23,1
10.056,7
85,6
1,4
1,2
17,3
2.115,5
18.0
-0,2
0,6
9,8
662,7
2.040,7
17,4
7,7
93,8
18,5
-1,5
18,9
1.775,0
15,1
4,5
N - Sistem Nervos
81,4
16,1
-2,4
18,8
1.533,6
13,1
-2,4
J - Anti-infecțioase
Sistemice
40,3
8.0
-4,8
29,5
1.188,3
10,1
-0,7
R - Sistem Respirator
54,9
10,9
0,1
15.0
823,7
7.0
-2,4
M – Sistem musculoscheletic
40,2
7,9
-1.0
14,4
579,9
4,9
-2,7
Alte grupe ATC1
69,6
13,8
-2.0
24,3
1.692,3
14,4
-5,6
Grupe ATC1
mil.
cutii
Cota de
piaţă (%)
Variaţie
(+/- %)
RON
mil. RON
Total
505,8
100.0
-1,1
23,2
Top grupe ATC1
436,2
86,2
-0,9
122,5
24,2
3,1
C - Sistem
Cardiovascular
L - Antineoplazice si
Imunomodulatoare
A - Sistem Digestiv si
Metabolism
6
This document should not be distributed without Cegedim authorization – Copyright 2011
Top 20 Corporații
Nr.
Trim. 4
2013
Corporaţie
Total piaţă
1
2
3
4
5
6
7
HOFFMANN LA ROCHE
SANOFI
1
2
NOVARTIS
SERVIER
PFIZER
3
4
GLAXOSMITHKLINE
MERCK & CO
5
6
7
∆
Trim.3
2013
2013
(mil. RON)
3.055,8
(mil. RON)
11.748,9
(%)
100,0
214,6
860,1
7,3
+1
213,1
827,5
7.0
-1
175,7
697,3
5,9
=
173,6
677,7
5,8
=
151,8
604,4
5,1
=
143,7
552,6
4,7
=
113,3
468,9
4.0
=
8
RANBAXY
121.0
453,5
3,9
+1
9
ASTRAZENECA
113,9
444,2
3,8
-1
10
KRKA
80,8
311,8
2,7
=
1.501,5
5.897,9
50,2
74,7
295,6
2,5
=
76,2
288,2
2,5
=
Subtotal Top 10
11
ANTIBIOTICE
8
12
JOHNSON & JOHNSON
13
TEVA
69,6
272,3
2,3
=
14
ABBVIE
71,1
263,7
2,2
=
15
MENARINI
66,2
253.0
2,2
=
16
BRISTOL MYERS SQUIBB
56,6
227,2
1,9
=
60,1
223.0
1,9
+1
9
17
BAYER HEALTHCARE AG
18
ALVOGEN
53,4
213,6
1,8
-1
19
ABBOTT
10
46,6
185,4
1,6
=
20
ELI LILLY
47,1
185.0
1,6
=
2.123,1
8.304,7
70,7
Subtotal Top 20
7
This document should not be distributed without Cegedim authorization – Copyright 2011
02
Perspective 2014
8
This document should not be distributed without Cegedim authorization – Copyright 2011
Primele 20 grupe terapeutice (ATC3)
Secondary Sales
mil. RON
Growth
1 L1X (ALL OTHER ANTINEOPLASTIC)
1,041.5
21.0%
2 L4B (ANTI-TNF PRODUCTS)
470.3
18.4%
3 N5A (ANTIPSYCHOTICS)
468.2
10.7%
4 C10A (CHOLESTEROL AND TRIGLYCERIDE REGULATING PREPARATIONS) 425.7
5.8%
5 A10C (HUMAN INSULINS AND ANALOGUES)
413.4
13.2%
6 J5C (HIV ANTIVIRALS)
387.8
3.6%
7 L3B (INTERFERONS)
383.0
4.9%
8 M1A (ANTI-RHEUMATICS, NON-STEROIDAL)
348.5
7.4%
9 N2B (NON-NARCOTICS AND ANTI-PYRETICS)
318.1
12.1%
10 C9A (ACE INHIBITORS, PLAIN)
279.4
1.6%
11 A2B (ANTIULCERANTS)
245.7
10.8%
12 C4A (CEREBRAL AND PERIPHERAL VASOTHERAPEUTICS)
229.6
-4.2%
13 B1C (PLATELET AGGREGATION INHIBITORS)
226.7
-9.7%
14 R5A (COLD PREPARATIONS WITHOUT ANTI-INFECTIVES)
220.5
9.1%
15 N4A (ANTI-PARKINSON DRUGS)
217.9
22.8%
16 C7A (BETA-BLOCKING AGENTS, PLAIN)
206.6
10.0%
17 J5B (ANTIVIRALS, EXCLUDING ANTI-HIV PRODUCTS)
198.2
26.2%
18 J1D (CEPHALOSPORINS)
197.0
10.5%
19 C1D (CORONARY THERAPY EXCLUDING CALCIUM ANTAGONISTS AND NITRITES)
191.2
0.5%
20 J1C (BROAD SPECTRUM PENICILLINS)
190.4
5.4%
Subtotal Top 20 ATC3
6,659.7
10.0%
ATC3 Group
Tertiary Sales
mil. RON
Growth
712.3
9.9%
440.1
24.2%
333.6
-12.3%
339.3
-7.2%
365.4
1.1%
286.5
-2.2%
314.4
7.3%
292.5
-1.3%
266.2
-1.5%
251.0
-3.6%
218.0
5.3%
210.2
-7.0%
192.4
-17.2%
177.5
7.9%
208.9
15.6%
182.1
3.0%
159.2
7.5%
175.4
0.4%
172.8
-4.1%
156.8
-5.4%
5,454.5
1.4%
9
This document should not be distributed without Cegedim authorization – Copyright 2011
Evoluție pe intervale valorice
Pret en-gros
2013
0: n/a
Unitati (mil.)
2012.0
1.0
% Pondere
2013.0
0.0
% Var
Valoare (mil. RON)
2,012.0
2012
2013
2013
0.3%
0.0%
-100.0%
26.5
2,013.0
% Pondere
% Var
2012
2013
2013
0.0
0.3%
0.0%
-100.0%
905.2
9.3%
9.1%
-3.0%
1: <10 RON
179.5
173.2 50.7%
49.6%
-3.5%
933.5
2: 10-25 RON
107.3
108.2 30.3%
31.0%
0.8%
1,760.6
1,740.4 17.5%
17.5%
-1.1%
3: 25-100 RON
53.5
55.5 15.1%
15.9%
3.7%
2,513.8
2,460.9 25.1%
24.7%
-2.1%
4: 100-250 RON
8.5
8.2
2.4%
2.4%
-3.6%
1,307.5
1,241.7 13.0%
12.5%
-5.0%
5: 250-1.000 RON
2.9
2.8
0.8%
0.8%
-3.2%
1,364.6
1,327.0 13.6%
13.3%
-2.7%
6: >1.000 RON
0.9
0.9
0.3%
0.3%
1.7%
2,125.8
2,282.6 21.2%
22.9%
7.4%
100.0%
-1.4%
10,032.2
9,957.9 100.0%
100.0%
-0.7%
Total
353.8
348.8 100.0%
10
This document should not be distributed without Cegedim authorization – Copyright 2011
Disponibilitate alternative terapeutice
Nivel
Subcategorie
Produse noi
Produse existente
Produs
Produse disponibile
Produse iesite
Brand-uri noi
Brand-uri existente
Brand
Brand-uri disponibile
Brand-uri iesite
DCI/combinatii noi
DCI/combinatii existente
DCI
DCI/combinatii disponibile
DCI/combinatii iesite
2012
469
3,415
3,884
346
217
1,851
2,068
156
51
886
937
33
2013
452
3,606
4,058
284
203
1,936
2,139
135
37
882
919
53
11
This document should not be distributed without Cegedim authorization – Copyright 2011
Perspective 2014
% Evolutie
Total Piata
Retail
Rx
OTC
Spital
2013
Prognoza
2013
Rezultat
2014
2015
2016
2017
2018
0.7%
1.3%
0.2%
6.6%
-2.9%
0.3%
0.4%
-0.8%
6.5%
-0.5%
2.7%
2.9%
2.5%
4.8%
1.5%
5.3%
5.5%
7.1%
-1.8%
4.1%
6.9%
6.6%
6.5%
7.1%
8.9%
6.3%
5.8%
5.4%
7.8%
9.3%
3.3%
3.0%
2.6%
5.0%
5.3%
Rata de Crestere Medie Compusa (CAGR) = 4,8%
12
This document should not be distributed without Cegedim authorization – Copyright 2011
03
Intrebări şi răspunsuri
13
This document should not be distributed without Cegedim authorization – Copyright 2011
Intrebări şi răspunsuri
 Acum e rândul dvs…
14
This document should not be distributed without Cegedim authorization – Copyright 2011
Thank you for your attention
 Email: [email protected]
www.cegedim.com

similar documents